Safety and immunogenicity of the intradermal thai red cross (2-2-2-0-1-1) post exposure vaccination regimen in the Indian population using purified chick embryo cell rabies vaccine

Indian Journal of Medical Microbiology

Volumn 23, Issue 1, 2005, Pages 24-28

  Chhabra, Mala ^a   Ichhpujani, R L ^a   Bhardwaj, M ^a   Tiwari, K N ^b   Panda, R C ^b   Lal, S ^a  

^a NATIONAL INSTITUTE OF COMMUNICABLE DISEASES   (India)

^b Municipal Corporation of Delhi   (India)

Author keywords

Intradermal administration; Post exposure prophylaxis; Rabies; Rabies antibody; Tissue culture rabies vaccine

Indexed keywords

RABIES VACCINE; TISSUE CULTURE MEDIUM;

ADULT; ARTICLE; BRAIN NERVE CELL; CHICK EMBRYO; DRUG DOSE REGIMEN; DRUG FORMULATION; DRUG PURIFICATION; DRUG SAFETY; EDEMA; EMBRYO CELL; ERYTHEMA; FEASIBILITY STUDY; FEMALE; FEVER; HEADACHE; HEALTH CENTER; HUMAN; HUMAN EXPERIMENT; IMMUNOGENICITY; INDIA; INDIAN; INJECTION PAIN; MALE; NONHUMAN; NORMAL HUMAN; OCCUPATIONAL EXPOSURE; RABIES; RED CROSS; SHEEP; SKIN ULCER; SYSTEMIC DISEASE; THAILAND; URTICARIA; VACCINATION;

EID: 14844335710     PISSN: 02550857     EISSN: None     Source Type: Journal    
DOI: 10.4103/0255-0857.13868     Document Type: Article

References (12)

1. Chhabra M, Ichhpujani RL. Animal Bites: the current management guidelines. Indian Pediatr 2003;70(1): S11-6
2. Eighth Report of the WHO Expert committee on Rabies. Geneva: World Health Organization; 1992. (WHO Technical Report Series, No.824)
3. Regional Strategy for elimination of rabies. WHO/SEARO document SEA/Rabies/22 July 1998.
4. Post-exposure treatment and the correct technique of intradermal immunization against rabies. Geneva: World Health Organisation; 1997.
5. Intradermal application of rabies vaccines, Report of a WHO Consultation, Bangkok, Thailand, 5-6 June, 2000.
6. Briggs DJ, Banzhoff A, Nicolay U, Sirikwin S, Dumavibhat B, Tongswas S, Wasi C. Antibody response of patients after post exposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified vero cell rabies vaccine. Bulletin of WHO 2000; 78(5): 693-8.
7. Madhusudna SN, Anand NP. Response to Purified chick Embryo Cell Rabies Vaccine administered intradermally for post exposure prophylaxis. Natl Med J India 1997;10:115-116.
8. Charanasri U, Meesoboon V, Kingnate D, Samuthananont P, Charychomsri W. Intradermal simulated rabies post exposure prophylaxis using purified chick embryo vaccine. J Med Assoc Thai 1994; 77(3) 157-60.
9. Arai YT, Kimura M, Sakaue Y, Hamada A, Yamada K, Nakayama M, Takasaki T, Kurane I. Antibody responses induced by immunization with a Japanese rabies vaccine determined by neutralization test and enzyme-linked immunosorbent assay. Vaccine 2002;20:2448-53.
10. Cliquet F, Sagne L, Schereffer JL, Aubert MFA. ELISA test for rabies antibody titration in orally vaccinated foxes samples in the fields. Vaccine 2000;18:3272-79.
11. Sampath G. Alternatives to NTV in India. Association for Prevention and Control of Rabies in India (APCRI) Journal 2002;IV (1,2):37-39.
12. Madhusudna SN, Anand NP, Shamsunder R. Evaluation of two intradermal vaccination regimens using purified chick embryo cell vaccine for post exposure prophylaxis of rabies. Natl Med J India 2001; 14(3): 145-147.